SCHEMBL8327636

SCHEMBL8327636

CCOC(=O)C(OC)(C(=O)O)c1ncccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 1/20 0.40
TSHR P16473 2/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 2/20 0.36
GAA P10253 2/20 0.36
ALDH1A1 P00352 4/20 0.35
RECQL P46063 1/20 0.35
MMP8 P22894 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BRD4 O60885 1/20 0.35
POLB P06746 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8327633 0.92 TSHR (0.39) PIN1TSHRNPC1LMNAGAA
SCHEMBL8332116 0.86 PIN1 (0.36) PIN1TSHRALDH1A1RECQLMMP8
SCHEMBL8329338 0.82 PIN1 (0.42) PIN1TSHRLMNAGAAALDH1A1
SCHEMBL8329336 0.77 LMNA (0.44) PIN1TSHRNPC1LMNAGAA
SCHEMBL8332643 0.77 PIN1 (0.39) PIN1TSHRALDH1A1RECQLMMP8
SCHEMBL8330071 0.76 SMN1; SMN2 (0.44) PIN1TSHRLMNAALDH1A1SMN1; SMN2
SCHEMBL3739399 0.75 TSHR (0.48) PIN1TSHRNPC1LMNAGAA
SCHEMBL8327638 0.75 PIN1 (0.41) PIN1TSHRNPC1LMNAGAA
SCHEMBL17007916 0.72 SMN1; SMN2 (0.40) PIN1TSHRNPC1LMNAGAA
SCHEMBL8332642 0.71 CASP1 (0.40) PIN1TSHRGAAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5908863-A ANTIGROWTH AGENT FOR BONES DOMPE' S.P.A. (IT) 1999-06-01 US disclosed
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed